FDA label 496a0012-6672-1006-e063-6294a90af488

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

SPL set ID: 21d04d5d-48cf-2155-e063-6294a90a59d2
SPL ID: 496a0012-6672-1006-e063-6294a90af488
Version: 2
Effective date: 2026-01-27
Source export date: 2026-10-12
Source partition: 1
Source file: https://download.open.fda.gov/drug/label/drug-label-0001-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-10-12/7928c8e8c6256620071a8b7e5b93eb8dfa543649c08d17a01ea02251012ba58c/drug-label-0001-of-0014.json.zip
Source manifest SHA-256: 7e6b178df8f32cac9a78e0f5d09c588344509b04fe41effb1dde9102e2a45be6
Import run: 20261013T011858Z
Imported at: 2026-10-13 01:25:10

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 2 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
spl id		496a0012-6672-1006-e063-6294a90af488	id
spl set id		21d04d5d-48cf-2155-e063-6294a90a59d2	set_id

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings The administration of Brain Rehabilitation may lead to certain adverse reactions, including gastrointestinal symptoms (such as nausea, abdominal discomfort, anorexia, bloating, and abdominal pain), These symptoms are generally mild and tend to resolve upon discontinuation of the drug.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.